BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 1626537)

  • 1. The changing pattern of human immunodeficiency virus type 1 infection in intravenous drug users. Results of a six-year seroprevalence study in Palermo, Italy.
    Romano N; Vitale F; Alesi DR; Bonura F; La Licata R; Intonazzo V; Dardanoni G; Mammina C
    Am J Epidemiol; 1992 Jun; 135(11):1189-96. PubMed ID: 1626537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy.
    Quaglio GL; Lugoboni F; Pajusco B; Sarti M; Talamini G; Mezzelani P; Des Jarlais DC;
    J Viral Hepat; 2003 Sep; 10(5):394-400. PubMed ID: 12969192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
    Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
    J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of viral infections among intravenous drug users in northern California.
    Zeldis JB; Jain S; Kuramoto IK; Richards C; Sazama K; Samuels S; Holland PV; Flynn N
    West J Med; 1992 Jan; 156(1):30-5. PubMed ID: 1310362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V; Zimatore G; Izzi A; Caroleo B; Rocca A; Montesano F; Costa C; Masciari R; Naso E; Biselli R
    J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infection by HIV and the hepatitis B, C, and D viruses in intravenous drug addicts. Seroprevalence at 1 year and its follow-up].
    Delgado-Iribarren A; Wilhelmi I; Padilla B; Cañedo T; Gómez J; Elviro J
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):8-13. PubMed ID: 8384891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: a cross-sectional study.
    Camoni L; Regine V; Salfa MC; Nicoletti G; Canuzzi P; Magliocchetti N; Rezza G; Suligoi B;
    Scand J Infect Dis; 2009; 41(6-7):520-3. PubMed ID: 19415569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and prevalence trends of HIV infection in intravenous drug users attending treatment centers in Milan and northern Italy, 1986-1990.
    Nicolosi A; Leite ML; Molinari S; Musicco M; Saracco A; Lazzarin A
    J Acquir Immune Defic Syndr (1988); 1992; 5(4):365-73. PubMed ID: 1548572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
    Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus (HIV) infection in parenteral drug users: evolution of the epidemic over 10 years. Valencian Epidemiology and Prevention of HIV Disease Study Group.
    Hernández-Aguado I; Aviño MJ; Pérez-Hoyos S; González-Aracil J; Ruiz-Pérez I; Torrella A; García de la Hera M; Belda F; Fernández E; Santos C; Trullen J; Fenosa A
    Int J Epidemiol; 1999 Apr; 28(2):335-40. PubMed ID: 10342700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China.
    Garten RJ; Lai S; Zhang J; Liu W; Chen J; Vlahov D; Yu XF
    Int J Epidemiol; 2004 Feb; 33(1):182-8. PubMed ID: 15075167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan.
    Ruzibakiev R; Kato H; Ueda R; Yuldasheva N; Hegay T; Avazova D; Kurbanov F; Zalalieva M; Tuichiev L; Achundjanov B; Mizokami M
    Intervirology; 2001; 44(6):327-32. PubMed ID: 11805437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for human immunodeficiency virus infection in 581 intravenous drug users, northeast Italy, 1984-1988. The AIDS and Related Syndromes Study Group.
    Serraino D; Franceschi S; Vaccher E; Diodato S; Santini GF; La Vecchia C; Hayes R; Tirelli U
    Int J Epidemiol; 1991 Mar; 20(1):264-70. PubMed ID: 2066233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y; Liu Y; Zou X; Chen W; Ling L
    BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.